Petr Makhov
Overview
Explore the profile of Petr Makhov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
115
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Topchu I, Bychkov I, Roshchina E, Makhov P, Boumber Y
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539515
Head and neck squamous cell carcinoma (HNSCC) ranks among the most prevalent global cancers. Despite advancements in treatments, the five-year survival rate remains at approximately 66%. The histone methyltransferase NSD1,...
2.
Topchu I, Bychkov I, Gursel D, Makhov P, Boumber Y
Cell Death Discov
. 2024 Feb;
10(1):75.
PMID: 38346948
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. Despite advances in therapeutic management and immunotherapy, the 5-year survival rate for head and neck cancer...
3.
Topchu I, Bychkov I, Gursel D, Makhov P, Boumber Y
bioRxiv
. 2023 Oct;
PMID: 37786686
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. Despite advances in therapeutic management and immunotherapy, the five-year survival rate for head and neck cancer...
4.
Bychkov I, Deneka A, Topchu I, Pangeni R, Lengner C, Karanicolas J, et al.
bioRxiv
. 2023 Jul;
PMID: 37398283
Significance: This study shows the novel role of Musashi-2 as regulator of ATM expression and DDR in lung cancer.
5.
Bychkov I, Topchu I, Makhov P, Kudinov A, Patel J, Boumber Y
Cancers (Basel)
. 2023 May;
15(9).
PMID: 37173995
Lung cancer is the most frequently diagnosed cancer type and the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) represents most of the diagnoses of lung cancer....
6.
Bychkov I, Topchu I, Makhov P, Kudinov A, Patel J, Boumber Y
bioRxiv
. 2023 Apr;
PMID: 37034813
Lung cancer is the most frequently diagnosed cancer type and the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) represents most of the lung cancer. Vascular endothelial...
7.
Aghayev T, Mazitova A, Fang J, Peshkova I, Rausch M, Hung M, et al.
Cancer Discov
. 2022 Jun;
12(8):1960-1983.
PMID: 35723626
Significance: HCC, the most common form of liver cancer, is characterized by a poor survival rate and limited treatment options. The discovery of a novel IL27-dependent mechanism controlling anticancer cytotoxic...
8.
Makhov P, Bychkov I, Faezov B, Deneka A, Kudinov A, Nicolas E, et al.
Oncogenesis
. 2021 Mar;
10(3):29.
PMID: 33723247
Non-small cell lung cancer (NSCLC) has limited treatment options. Expression of the RNA-binding protein (RBP) Musashi-2 (MSI2) is elevated in a subset of non-small cell lung cancer (NSCLC) tumors upon...
9.
Zhao Z, Kurimchak A, Nikonova A, Feiser F, Wasserman J, Fowle H, et al.
Oncogenesis
. 2019 Dec;
8(12):72.
PMID: 31822657
The PPP2R2A gene encodes the B55α regulatory subunit of PP2A. Here, we report that PPP2R2A is hemizygously lost in ~42% of prostate adenocarcinomas, correlating with reduced expression, poorer prognosis, and...
10.
Peshkova I, Aghayev T, Fatkhullina A, Makhov P, Titerina E, Eguchi S, et al.
Nat Commun
. 2019 Nov;
10(1):5046.
PMID: 31695038
Abdominal aortic aneurysm (AAA) is a prevalent life-threatening disease, where aortic wall degradation is mediated by accumulated immune cells. Although cytokines regulate inflammation within the aorta, their contribution to AAA...